Patents by Inventor Xuehong Luo

Xuehong Luo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20230406851
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: January 26, 2023
    Publication date: December 21, 2023
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20220062290
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: November 10, 2021
    Publication date: March 3, 2022
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20210228588
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: April 8, 2021
    Publication date: July 29, 2021
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20200390779
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: August 27, 2020
    Publication date: December 17, 2020
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20200138826
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: January 7, 2020
    Publication date: May 7, 2020
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20190231789
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: April 4, 2019
    Publication date: August 1, 2019
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20190030040
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: February 27, 2018
    Publication date: January 31, 2019
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Imidazopyridine compounds and uses thereof
    Patent number: 9937185
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Grant
    Filed: September 26, 2017
    Date of Patent: April 10, 2018
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • IMIDAZOPYRIDINE COMPOUNDS AND USES THEREOF
    Publication number: 20180015099
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: September 26, 2017
    Publication date: January 18, 2018
    Inventors: Christophe BUON, Louis-David CANTIN, Yun-Jin HU, Xuehong LUO, Miroslaw Jerzy TOMASZEWSKI
  • Imidazopyridine compounds and uses thereof
    Patent number: 9814725
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processesor making such a compound, and intermediates used in such processes.
    Type: Grant
    Filed: February 2, 2017
    Date of Patent: November 14, 2017
    Assignee: NEOMED INSTITUTE
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Imidazopyridine Compounds and Uses Thereof
    Publication number: 20170143730
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: February 2, 2017
    Publication date: May 25, 2017
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Imidazopyridine compounds and uses thereof
    Patent number: 9598409
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Grant
    Filed: January 31, 2014
    Date of Patent: March 21, 2017
    Assignee: Neomed Institute
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Imidazopyridine Compounds and Uses Thereof
    Publication number: 20150361078
    Abstract: This invention generally relates to substituted imidazopyridine compounds, particularly substituted 4-(imidazo[1,2-a]pyridin-2-yl)benzamide compounds and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: January 31, 2014
    Publication date: December 17, 2015
    Inventors: Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Benzoimidazole compounds and uses thereof
    Patent number: 8530467
    Abstract: This invention generally relates to substituted benzoimidazole compounds, particularly methyl 2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Grant
    Filed: May 16, 2012
    Date of Patent: September 10, 2013
    Assignee: Neomed Institute
    Inventors: Louis-David Cantin, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Benzoimidazole Compounds and Uses Thereof
    Publication number: 20120289504
    Abstract: This invention generally relates to substituted benzoimidazole compounds, particularly methyl 2-((2-(2,6-difluoro-4-(methylcarbamoyl)phenyl)-5-methyl-1H-benzo[d]imidazol-1-yl)methyl)morpholine-4-carboxylate and salts thereof. This invention also relates to pharmaceutical compositions and kits comprising such a compound, uses of such a compound (including, for example, treatment methods and medicament preparations), processes for making such a compound, and intermediates used in such processes.
    Type: Application
    Filed: May 16, 2012
    Publication date: November 15, 2012
    Applicant: ASTRAZENECA AB
    Inventors: Louis-David Cantin, Xuehong Luo, Miroslaw Jerzy Tomaszewski
  • Piperidine derivatives and their use as muscarinic receptor modulators
    Patent number: 8119661
    Abstract: Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein R2, R3, X, m and n are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Grant
    Filed: September 8, 2008
    Date of Patent: February 21, 2012
    Assignee: AstraZeneca AB
    Inventors: Yun-Xing Cheng, Xuehong Luo, Vijayaratnam Santhakumar, Miroslaw Jerzy Tomaszewski
  • MUSCARINIC RECEPTOR AGONISTS, COMPOSITIONS, METHODS OF TREATMENT THEREOF, AND PROCESSES FOR PREPARATION THEREOF 177
    Publication number: 20090221567
    Abstract: Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein Y, X, A, R1, R2, m, p, and q are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: February 25, 2009
    Publication date: September 3, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Yun-Xing Cheng, Xuehong Luo, Mehrnaz Pourashraf, Vijayaratnam Santhakumar, Miroslaw Jerzy Tomaszewski
  • Therapeutic Compounds 570
    Publication number: 20090099195
    Abstract: Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R1, R2, R3, R4, and R5 and are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: May 5, 2008
    Publication date: April 16, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Malken Bayrakdarian, Christophe Buon, Louis-David Cantin, Yun-Jin Hu, Xuehong Luo, Vijayaratnam Santhakumar, Miroslaw Tomaszewski
  • New compounds 966
    Publication number: 20090076078
    Abstract: Compounds of Formula I, or pharmaceutically acceptable salts thereof: wherein R2, R3, X, m and n are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: September 8, 2008
    Publication date: March 19, 2009
    Applicant: ASTRAZENECA AB
    Inventors: Yun-Xing Cheng, Xuehong Luo, Vijayaratnam Santhakumar, Miroslaw Jerzy Tomaszewski
  • Novel Compounds
    Publication number: 20070259888
    Abstract: Compounds of Formulae I, or pharmaceutically acceptable salts thereof: wherein X, R1, R2 and R3 are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    Type: Application
    Filed: April 30, 2007
    Publication date: November 8, 2007
    Applicant: ASTRAZENECA AB
    Inventors: Yun-Xing Cheng, Xuehong Luo, Miroslaw Tomaszewski